Rankings
▼
Calendar
LTRN Q1 2023 Earnings — Lantern Pharma Inc. Revenue & Financial Results | Market Cap Arena
LTRN
Lantern Pharma Inc.
$31M
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.32
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$4M
Free Cash Flow
-$4M
Stock-Based Comp.
$333,530
Balance Sheet
Total Assets
$56M
Total Liabilities
$3M
Stockholders' Equity
$53M
Cash & Equivalents
$33M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$4M
-$4M
-5.4%
Net Income
-$4M
-$4M
+6.2%
← FY 2023
All Quarters
Q2 2023 →